User profiles for J Stebbing
Justin StebbingImperial College Verified email at imperial.ac.uk Cited by 33157 |
[HTML][HTML] PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
The PI3K/AKT/mTOR (PAM) signaling pathway is a highly conserved signal transduction
network in eukaryotic cells that promotes cell survival, cell growth, and cell cycle progression. …
network in eukaryotic cells that promotes cell survival, cell growth, and cell cycle progression. …
Clinical characteristics and outcomes of COVID-19–infected cancer patients: a systematic review and meta-analysis
…, H Chen, V Velcheti, J Stebbing… - JNCI: Journal of the …, 2021 - academic.oup.com
Background Previous studies have indicated coronavirus disease 2019 (COVID-19) patients
with cancer have a high fatality rate. Methods We conducted a systematic review of studies …
with cancer have a high fatality rate. Methods We conducted a systematic review of studies …
Circulating tumor cells in breast cancer patients treated by neoadjuvant chemotherapy: a meta-analysis
…, L Muinelo-Romay, J Stebbing… - JNCI: Journal of the …, 2018 - academic.oup.com
Background We conducted a meta-analysis in nonmetastatic breast cancer patients treated
by neoadjuvant chemotherapy (NCT) to assess the clinical validity of circulating tumor cell (…
by neoadjuvant chemotherapy (NCT) to assess the clinical validity of circulating tumor cell (…
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
…, A Phelan, M Rawling, E Savory, J Stebbing - The lancet, 2020 - thelancet.com
Given the scale and rapid spread of the 2019 novel coronavirus (2019-nCoV) acute respiratory
disease, there is an immediate need for medicines that can help before a vaccine can be …
disease, there is an immediate need for medicines that can help before a vaccine can be …
[HTML][HTML] COVID-19: combining antiviral and anti-inflammatory treatments
J Stebbing, A Phelan, I Griffin, C Tucker… - The Lancet Infectious …, 2020 - thelancet.com
The Lancet, 3 we described how BenevolentAI’s proprietary artificial intelligence (AI)-derived
knowledge graph, 4 queried by a suite of algorithms, enabled identification of a target and …
knowledge graph, 4 queried by a suite of algorithms, enabled identification of a target and …
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
…, D Generali, JA Garcia-Saenz, J Stebbing… - The lancet …, 2014 - thelancet.com
Background We aimed to assess the clinical validity of circulating tumour cell (CTC) quantification
for prognostication of patients with metastatic breast cancer by undertaking a pooled …
for prognostication of patients with metastatic breast cancer by undertaking a pooled …
Mechanism of baricitinib supports artificial intelligence‐predicted testing in COVID‐19 patients
J Stebbing, V Krishnan, S de Bono… - EMBO molecular …, 2020 - embopress.org
Baricitinib is an oral Janus kinase ( JAK )1/ JAK 2 inhibitor approved for the treatment of
rheumatoid arthritis ( RA ) that was independently predicted, using artificial intelligence ( AI ) …
rheumatoid arthritis ( RA ) that was independently predicted, using artificial intelligence ( AI ) …
[PDF][PDF] Highly active antiretroviral therapy and the incidence of non–AIDS-defining cancers in people with HIV infection
T Powles, D Robinson, J Stebbing, J Shamash… - Journal of Clinical …, 2009 - Citeseer
… J Natl Cancer Inst 92:1823-1830, 2000 5. Herida M, Mary-Krause M, Kaphan R, et al:
Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral …
Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral …
Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence
…, S Ahmed, S Ali, S Cleator, L Kenny, J Stebbing… - Clinical Cancer …, 2019 - AACR
Purpose: Up to 30% of patients with breast cancer relapse after primary treatment. There
are no sensitive and reliable tests to monitor these patients and detect distant metastases …
are no sensitive and reliable tests to monitor these patients and detect distant metastases …
The estrogen receptor-α-induced microRNA signature regulates itself and its transcriptional response
…, J Waxman, GJ Hannon, J Stebbing - Proceedings of the …, 2009 - National Acad Sciences
Following estrogenic activation, the estrogen receptor-α (ERα) directly regulates the
transcription of target genes via DNA binding. MicroRNAs (miRNAs) modulated by ERα have the …
transcription of target genes via DNA binding. MicroRNAs (miRNAs) modulated by ERα have the …